Etilaam 1.5 CR Tablet

By Etilaam

Rx

10 Tablet CR in a Strip

Composition icon

Composition

Etizolam(1.5mg)

Manufacturer - Intas Pharmaceuticals Ltd icon

Manufacturer - Intas Pharmaceuticals Ltd

Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after icon

Expires on or after

August, 2025

About Etilaam 1.5 CR Tablet

Etilaam 1.5 CR Tablet is a prescription medication that belongs to the class of anxiolytics, which are anxiety-reducing drugs. It is primarily used to treat anxiety disorders, panic disorder, and insomnia. Anxiety is a mental health condition characterized by feelings of fear, worry, and excessive nervousness, while insomnia is a sleep disorder that causes difficulties in falling asleep or staying asleep. Panic disorder, another condition treated by Etilaam 1.5 CR Tablet, involves sudden and intense feelings of fear even in the absence of real danger.

This medication works by binding to specific receptor sites in the brain, leading to increased activity of GABA, a natural nerve-calming chemical messenger. By doing so, Etilaam 1.5 CR Tablet induces relaxation, reduces anxiety levels, and helps in falling asleep. It also relaxes muscles, making it beneficial for treating fits episodes. It is essential to follow the doctor's instructions regarding dosage and duration, as Etilaam 1.5 CR Tablet has a high potential for habit-forming.

Etilaam 1.5 CR Tablet can be taken with or without food, but it is crucial to take it at the same time each day to maintain a consistent level of the medication in the body. If a dose is missed, it should be taken as soon as remembered, and the full course of treatment should be completed even if symptoms improve. Abruptly stopping the medication without consulting a healthcare provider may lead to adverse effects such as nausea and anxiety.

Common side effects of Etilaam 1.5 CR Tablet include headaches, impaired muscle coordination, slurred speech, muscle weakness, altered libido, and depression. Additionally, it may cause dizziness and sleepiness, warranting caution when engaging in activities that require mental focus, such as driving. Patients should consult their doctor about possible side effects, ways to manage them, and the need for ongoing monitoring of blood and liver functions if using the medication long-term.

Before starting Etilaam 1.5 CR Tablet, patients should inform their doctor if they are pregnant, planning pregnancy, or breastfeeding. It is generally safe to use Etilaam 1.5 CR Tablet with other medications, but some substances like antacids and alcohol may interact with it, potentially increasing the risk of side effects. Elderly patients should use this medication with caution, as they may be at higher risk of adverse reactions such as dizziness, muscle weakness, and drowsiness. Additionally, mixing Etilaam 1.5 CR Tablet with opioids can lead to severe breathing problems, emphasizing the importance of discussing all existing medical conditions and medications with a healthcare provider before starting this treatment.


Benefits

Etilaam 1.5 CR Tablet offers key benefits in the treatment of short-term anxiety and insomnia. In the case of short-term anxiety, this medication effectively reduces symptoms of excessive anxiety and worry that arise during stressful conditions like job interviews, exams, or stage performances. It helps manage feelings of restlessness, tiredness, difficulty concentrating, and irritability, allowing individuals to carry out their daily activities with more ease and productivity. It is essential to continue taking Etilaam 1.5 CR Tablet even when feeling well, as suddenly stopping the medication can lead to serious problems.

Moreover, Etilaam 1.5 CR Tablet is also beneficial for treating insomnia, a condition characterized by difficulty falling or staying asleep. This medication works by slowing down brain activity, promoting relaxation to facilitate sleep. By improving sleep quality, Etilaam 1.5 CR Tablet helps individuals feel more energetic, concentrate better, and ultimately enhances their overall quality of life. Etilaam 1.5 CR Tablet acts as an anxiolytic drug, targeting anxiety and panic disorder over a short period, as well as addressing insomnia issues by increasing the activity of GABA, a natural nerve-calming agent in the brain. By relaxing muscles, reducing anxiety levels, and supporting a good night's sleep, Etilaam 1.5 CR Tablet assists individuals in managing their symptoms effectively.


How to use the Etilaam 1.5 CR Tablet

To use Etilaam 1.5 CR Tablet, follow your doctor's instructions on dosage and duration carefully. Swallow the tablet whole with a glass of water. It is important not to chew, crush, or break the tablet. You can take Etilaam 1.5 CR Tablet with or without food, but it is recommended to take it at the same time every day for better results. Remember not to handle the tablet with wet hands. If you have the tablet MD version, follow the instructions to allow it to dissolve slowly in your mouth without swallowing. Always consult your doctor for the best way to use Etilaam 1.5 CR Tablet.


Uses of Etilaam 1.5 CR Tablet

Etilaam 1.5 CR Tablet is primarily used in the treatment of short-term anxiety and insomnia. This medication is specifically helpful for relieving symptoms related to anxiety disorders, panic disorders, and insomnia, which is a common sleep disorder. It is prescribed to assist individuals in managing their symptoms of anxiety and insomnia by providing relief from associated distress and sleep disturbances. When taken as directed by a healthcare provider, Etilaam 1.5 CR Tablet can support individuals in coping better with short-term anxiety and improving their quality of sleep when experiencing insomnia.


What conditions Etilaam 1.5 CR Tablet treats?

Etilaam 1.5 CR Tablet is commonly used to treat anxiety, which is a mental health disorder characterized by fear, worry, and excessive nervousness. Symptoms of anxiety include feeling stressed beyond what is required for a situation and difficulty controlling restlessness and worry. Additionally, this medication may be prescribed for insomnia, a sleep disorder that can lead to trouble falling or staying asleep. Insomnia can be acute, lasting from one night to a few weeks, or chronic, lasting more than 3 nights per week for over 3 months. Various factors like depression, stress, anxiety, and certain lifestyle habits can contribute to insomnia.


Should you consult a doctor?

Seek medical attention if you experience severe or persistent side effects such as confusion, altered libido, depression, fainting, or visual impairment while taking Etilaam 1.5 CR Tablet. Additionally, if you notice symptoms like tremors, drowsiness, impaired muscle coordination, slurred speech, severe headache, or muscle weakness, consult your healthcare provider. It is crucial to contact your doctor if you have concerns about any side effects or if they do not improve over time. Remember to inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting this medication. Regular monitoring of blood and liver functions may be necessary if you use Etilaam 1.5 CR Tablet for an extended period. Always follow the dosage instructions provided by your doctor to avoid potential habit-forming effects and consult them before making any changes to your treatment plan.


Side effects of Etilaam 1.5 CR Tablet

When taking Etilaam 1.5 CR Tablet, some individuals may experience side effects as their bodies adjust to the medication. These side effects, although common, usually do not necessitate medical attention and tend to fade away over time. However, it is advisable to consult your doctor if they persist or cause concern. Some possible side effects of Etilaam 1.5 CR Tablet include altered libido, confusion, depression, drowsiness, fainting, headaches, impaired muscle coordination, muscle weakness, sedation, slurred speech, tremors, and visual impairment. Additionally, individuals may also experience drowsiness, ataxia affecting balance and coordination, dysarthria manifesting as difficulty speaking, nystagmus involving involuntary eye movement, and blepharospasm characterized by involuntary eyelid closure. If any of these side effects become bothersome or worrisome, seeking guidance from a healthcare professional is recommended for appropriate management.


Safety advice

scroll

liver

Caution should be exercised when taking Etilaam 1.5 CR Tablet, especially if you have a history of liver diseases or conditions. It is important to consult your doctor before using this medication, as there is limited information available on its use in patients with liver disease. Your doctor may need to adjust the dosage according to your specific situation.

scroll

kidney

Limited information is available on the use of Etilaam 1.5 CR Tablet in patients with kidney disease. It is advisable to consult a doctor if you have any concerns regarding the use of this medication in individuals with kidney problems.

scroll

alcohol

Consult your doctor when consuming alcohol with Etilaam 1.5 CR Tablet as its safety is unknown. Alcohol may increase drowsiness and other adverse effects when taken with Elm-CR Tablet 10's.

scroll

driving

Etilaam 1.5 CR Tablet may cause side effects like sedation and muscle relaxation, which can impair driving ability. Avoid driving if experiencing drowsiness, dizziness, or vision issues after taking Etilaam 1.5 CR Tablet.

scroll

pregnancy

The safety of using Etilaam 1.5 CR Tablet during pregnancy is uncertain. It is classified as a Category C pregnancy drug. Please consult your doctor if you are pregnant or planning to become pregnant.

scroll

breastfeeding

It is better to consult your doctor before using Etilaam 1.5 CR Tablet during breastfeeding.


Consumption warning before consuming Etilaam 1.5 CR Tablet

Before taking Etilaam 1.5 CR Tablet, it is important to note the following precautions. Avoid using this medication if you are pregnant or breastfeeding due to potential harmful effects on the baby. Elderly patients should use Etilaam 1.5 CR Tablet with caution, as they are at higher risk for adverse reactions like dizziness, muscle weakness, and drowsiness. Inform your healthcare provider if you have conditions like myasthenia gravis, chronic pulmonary insufficiency, drug addiction, or kidney/liver problems before starting Etilaam 1.5 CR Tablet. Additionally, do not combine this medication with opioids, as it can lead to serious complications such as breathing difficulties, extreme drowsiness, coma, and even death. Always follow your doctor's advice and disclose your complete medical history to ensure safe usage of Etilaam 1.5 CR Tablet.


What if you forgot to take Etilaam 1.5 CR Tablet?

If you happen to forget to take your Etilaam 1.5 CR Tablet at the scheduled time, try to take it as soon as you remember. But if it's nearly time for your next dose, it's best to skip the missed dose and continue with your regular dosing schedule. Avoid taking a double dose to make up for the missed one, as this can increase the risk of side effects. It's important to maintain a consistent dosing routine to ensure the medication works effectively.


Additional Information

Habit FormingNo
Chemical ClassThienodiazepines Derivative
Therapeutic ClassNEURO CNS
Action ClassBenzodiazepines

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

141.5

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 11-Feb-2025